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Abstract 
 
Universal prenatal screening services for Down’s syndrome are growing fast and 
have important ethical dimensions. The medical and midwifery press scarcely 
consider these but concentrate on how to make screening more sensitive and 
specific, cost-effective, and open to prospective parents’ choices. Emphases in 
mainstream bioethics on cost-benefit analysis, respect for the rational autonomous 
person, on freedom of  choice, and non-maleficence, which now includes the notion 
of preventing a wrongful life, can all be used to condone screening for Down’s 
syndrome. Mainstream bioethics is compared with more critical approaches. 
Professional and mainstream bioethics concerns can divert attention from two prior 
questions considered in this paper: Why screen for Down’s syndrome? And on what 
evidence and logic are the arguments which support screening based? 
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Introduction 
Over the past three decades, prenatal screening and bioethics have both expanded 
rapidly. They now affect Western prenatal care generally, in terms of how 
professional time, expertise and resources are organised and rationalised, in 
relationships between pregnant women and prenatal staff, and in professionals’ 
efforts to prevent litigation and to offer informed choice. This paper reviews the 
symbiosis between screening technologies and mainstream bioethics, taking Down’s 
syndrome as a case study. Rather than offering independent and critical analyses of 
prenatal practices, mainstream bioethics tends to reinforce the liberal assumptions 
underlying clinical policies.   
 
Prenatal tests over three decades 
There is an increasing trend towards universal prenatal testing for Down’s syndrome 
(Reid, 1990). The first antenatal diagnosis of Down’s syndrome by amniocentesis 
was made in 1968 (Wald et al., 1997). Since the 1980s, chorionic villus sampling 
has also been widely used. These invasive diagnostic tests are now usually 
preceded by maternal serum screening and/or ultrasound scanning to select 
pregnancies at higher risk of having Down’s syndrome. Serum screening is routinely 
offered to pregnancy women or administered not necessarily with their knowledge or 
consent (Green and Statham, 1996; Marteau et al., 1988). During the 1990s, 
screening for Down’s syndrome, through ultrasound scanning for a nuchal fold in the 
fetal neck, became more universally applied (Nicolaides et al., 19992). 
 
Birth rates and Down’s syndrome 
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In England, the rate of Down’s syndrome per 100,000 total births fell steadily from 
8.6 in 1982 to 5.7 in 1992 when 371 babies were born (OPCS, 1994) despite the 
rise in average maternal age. In 1996, 319 babies with Down’s syndrome were born 
(Mutton et al., 1998), although the birth rates may be under-estimated by about one 
half (Huang et al., 1997) and Olsen et al. (1996)  and Saridogan et al. (1996) found 
that screening has not reduced the live birth prevalence significantly. Wyllie et al. 
(1997) reported that of 412 pregnancies with Down’s syndrome, 78 per cent resulted 
in a live birth. 
 
Policies 
It is uncertain how many cases were ”missed” by screening, or how many women 
chose more or less deliberately to continue their pregnancy, and why, or how much 
the general public is concerned to reduce the birth rate of babies with Down’s 
syndrome.  
  The main drive towards introducing screening appears to come from medical 
agencies (Reid, 1991), not from lay people through public or parliamentary debate. 
In Britain, no laws regulate screening. Policies are formulated by expert (mainly 
medical and health economics) advisory committees, which issue guidance. 
Economics influences screening policies through three main aims: to reduce the “life 
time costs of care” for people with Down’s syndrome; to avoid costly litigation for 
“wrongful birth” of undiagnosed cases; and to develop comparatively cheaper 
although also profitable technologies. The estimated costs of £38,000 worth of 
screening “for each Down’s syndrome birth avoided” were compared with £120,000 
for the ”lifetime care” of an individual with Down’s syndrome (Wald et al,, 1992). This 
assumes a high rate of terminations after diagnosis, and further assumes that 
people with Down’s syndrome cannot contribute to society, and need expensive 
support, without providing any supporting evidence. Current screening costs appear 
to be too low, given the evidence of inadequately informed counselling (Smith et al., 
1994), and the need to train under-informed staff (Sadler, 1997). Close links 
between national policy making and commercial concerns are illustrated by the NHS 
Report which advocates universal antenatal screening for Down’s syndrome; the 
lead author is a director of the company which markets the necessary soft-ware 
(Wald et al., 1998). 
  Screening is complicated by high false positive and false negative rates. Some 
clinicians calculate a net gain to society, because of the severity of Down’s syndrome, of 
screening 100,000 pregnancies, involving 3,000 amniocentesis (2,960 with negative results) 
incurring the inadvertent miscarriage of 30 (one per cent) of unaffected fetuses, in order to 
reduce the incidence of Down’s syndrome from 100 to 60 live births. Two per cent of 
terminations are found to be unaffected (Painton, 1997). Others are less certain of the 
benefits. Fletcher et al. (1995) compared different screening policies for Down's 
syndrome using “a decision tree that combined data from local sources and the 
medical literature to predict the likely frequency of several outcomes. Sensitivity 
analyses were used to test the robustness of the conclusions drawn....Each option 
for screening for Down's syndrome that we considered had significant drawbacks. In 
Oxfordshire, offering serum testing to women of all ages would prevent the birth of 
approximately one more baby with Down's syndrome per year than would a policy of 
screening for women aged 30 years or more. The cost of preventing this one extra 
Down's birth would be one or two normal babies lost after amniocentesis, 4500 
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blood tests for young women (with the associated anxiety and counselling), 
approximately 200 false positive serum test results and amniocentesis (with the 
associated anxiety and distress), and £90,000 for the extra tests, counselling, and 
amniocentesis. Opinions are divided as to which policy is the better option for the 
population.” The authors advised focussing “debate and decision making on 
outcomes of care, which in turn makes it clear that the choice of screening 
programme for Down's syndrome depends on the relative importance ascribed to 
the different outcomes. If individuals' values vary widely it may be impossible to find 
one screening policy that meets the needs of all pregnant women.” 
  By 1998, universal maternal serum screening was officially proposed in the UK 
(Wald, et al., 1998).In an unusual step, the Netherlands Screening Act (1996) 
prohibited routine use of the serum test, and required that it be an opt-in test by 
request only. 
  The mass media tend to welcome new medical technologies including screening as 
signs of progress towards better health for all. Detailed cost-benefit considerations, 
such as those given by Fletcher et al. (1995) are not discussed in the public media. 
However, personal stories by parents about how highly they value their child who 
has Down’s syndrome occasionally appear in newspapers, midwifery and women’s 
magazines (Alderson, 1997). Yet these individual accounts are in marked contrast to 
the general media trend to stress the benefits of screening. The next sections give 
examples of related discussion in the British medical and midwifery literature.  
 
The medical literature 
This section reviews how the medical literature tends to assume negative views of 
Down’s syndrome as “the most common form of severe mental retardation” linked to 
“precocious dementia of Alzheimer type” (Takashima 1997). Abortion is seen as the 
only “effective remedy” and to some authors, prenatally, ethics becomes a matter of 
providing screening services which are “quantified and predictable” (Wald et al., 
1998:5).  
  Numerous papers report research, through fetal imaging, for more precise 
anatomical indicators of Down’s syndrome, such as relative chest size (Petrikovsky, 
et al., 1996) and “cardiac abnormalities, duodenal atresia, femur length, humerus 
length, pyelectasis, and hyperechogenic bowel” (Wald et al. 1997). In explaining the 
practical value of the research findings, Heuther et al., (1996) and others combine 
the contradictory aims of encouraging personal choice versus conducting public 
health programmes designed for the “continued reduction in incidence prevalence 
rates for Down’s syndrome through prenatal diagnosis and elective abortion,” a 
distinction which the geneticists Harper and Clarke (1997) repeatedly stress should 
be observed. 
  Medical journals also publish many items on how to refine prenatal tests and 
calculate their cost effectiveness (as found in a review of all copies of the British 
Medical Journal, 1994-1999, and on Medline). Serra-Pratt et al. (1998) define “major 
trade-offs” for certain screening programmes in terms of detection rates, false-
positive results, lower inadvertent fetal loss and costs. Methods of screening are 
also “validated” by evidence that they are cheaper than another type (for example, 
Vintzileos et al., 1998). 
  Another wide-spread concern is how to clarify decision making rules for pregnant 
women and staff. Cuckle et al. (1996) advise using “graphical information in 
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nomograms when counselling women considering whether or have maternal serum 
screening, using a statistical modelling of the frequency distribution of estimated 
Down's syndrome risk for four marker combinations: maternal age, detection and 
false-positive rates, and the proportion of pregnancies with different estimated risks.” 
They conclude that “when screening is offered, clinicians need to have information 
readily available on test accuracy and the likely result, which is specific to the 
individual.” Thornton (1994) uses diagrams of doorways to make “stark simple 
choices”, showing how choosing one option closes off others, in his efforts to speed 
and clarify decision-making. 
  Paediatric text books tend to describe Down’s syndrome negatively as Anot 
treatable@ (Goodman and Scott, 1997), or mention it only in reference to prenatal 
screening, (Cade et al., 1995). The journals also emphasise childhood pathology. 
Brookes and Albermarle (1996) followed up 100 children with Down’s syndrome to 
five years after birth, and found high mortality and morbidity rates. They concluded 
that “this negative information as well as that regarding the more positive aspects of 
Down's syndrome, should be made available to those counselling parents 
[prenatally]”. Records for nearly one third of the sample were not traced and, 
typically, the medical authors do not explain what the “more positive aspects”. In 
contrast, a study of 280 cases of Down’s syndrome, identified prenatally and 
followed up to one year after birth, attributed the poor health rates to lack of 
“necessary care” by parents and health professionals, and commented that the 
“influence of prenatal diagnosis of chromosome disorders as a determining factor of 
the social acceptance of Down’s syndrome is still questionable” and may partly 
account for sub-standard health care of affected children (Julian-Reynier et al., 
1995).  
  One in six children with Down’s syndrome has a heart defect. However, Abu-Harb 
et al., (1995) concluded that “screening for Down's syndrome is likely to have only a 
small effect on the requirements for paediatric cardiology services”, after reviewing 
1347 infants with heart disease in one region, and should not be a reason to attempt 
to economise on cardiac costs by terminating affected pregnancies. Despite the high 
incidence of heart defects, no one with Down’s syndrome, so far in Britain, has had a heart 
transplant. During publicity about Katie Atkinson aged 9 who has Down’s syndrome, when 
doctors refused to consider her for a transplant, the Department of Health stated in news 
bulletins on 26 July 1999 “there is certainly no ban on people with Down’s syndrome 
receiving organ transplants.” Clinicians cite the shorter life expectancy of people with 
Down’s syndrome as an obstacle, but less than half the heart transplantation cases survive for 
more than ten years (Heart 1999 82:47-51), an expected  survival time well within the 
lifetime of teenagers with Down’s syndrome. To deny treatment to children because of 
shorter life expectancy, and thereby to contribute to reducing their life span, becomes a 
circular argument.  
  Unpublished professional case reports, including medical statements of special 
educational need, often emphasise difficulty, inability and need, for the useful 
purpose of seeking to obtain more resources and services for the child. Many 
parents and Aself-help@ organisations similarly (over)emphasise the frequency and 
severity of the problems, believing that this will benefit affected people by increasing 
professional support and public funding. All such reports serve specific purposes, 
but may be mistaken for stating general comprehensive truths about the condition. 
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  Children with Down’s syndrome may be considered less worthy of costly care because of 
their average lower intelligence. Yet their IQ ranges from 10 up to 92 or almost normal 
(Lorenz 1984), and their educational achievements and expectations are rising considerably 
(Alderson and Goodey, 1998). Prenatal prognoses are complicated, not only by uncertainty 
about the severity of each case, but also by the immensely wide-ranging and unpredictable 
effects of future life style, social changes and opportunities for people with Down’s 
syndrome. Equally crucial are the attitudes of all concerned, for instance in seeing problems 
as insuperable barriers or as challenging opportunities. The medical literature mainly sees 
“mental retardation” as biological and immutable. In contrast, the disability literature sees 
“learning difficulties” as partly socially constructed (Morris, 1998; Ward 1997). As shown 
later, the two approaches encourage different ethical viewpoints.  
  Some notable exceptions in the medical literature are more cautious about prenatal screening 
and take greater account of social perspectives. Santalahti (1998) records women’s distress 
about screening and terminations, and Clarke (1997: 123) accepts that children “with Down’s 
syndrome often do not suffer physically. Because the promotion of prenatal screening for 
Down’s syndrome may actually promote the stigmatization and intolerance that is a major 
cause of the suffering experienced by many affected individuals and their families, it is not at 
all clear that such screening is helpful.” 
  Psychological surveys also tend to qualify the benefits of prenatal screening by 
measuring women’s anxiety and exploring ways of reducing this (for example, Green 
and Statham, 1996: Marteau and Coyle, 1998). For example, Kornman et al. (1997) 
reported that three quarters of the Dutch women they questioned would prefer first 
trimester testing because of  the easier termination of pregnancy and/or the earlier 
reassurance provided. 
 
The midwifery literature   
This literature emphasises the utilitarian ethics of providing efficient screening 
services, rather than questioning their overall value and justice, purpose and social 
effects. This observation is based on a review of articles on the computerised lists at 
the Royal College of Nursing and Royal College of Midwives libraries, and a hand 
search review of MIDIRS journal). Jokey titles like “It could be you” (Rogers, 1997), 
the slogan of the British lottery, suggest that “positive” test results are hardly seen as 
raising profound ethical problems. A rare reference to women’s distress attributes 
this to fear of the syndrome; “the prospect of having a child whose prognosis [with 
Down’s syndrome] is deemed very bleak by conventional medical opinion” (Grayson 
1996).  
  Most midwives support universal prenatal screening for Down’s syndrome 
(Fairgrieve et al., 1997; xSandall). Authors such as Ockenden (1997) report only the 
advantages of “informed choice”, and not possible drawbacks, that not all the 
choices may be informed or welcomed. The Royal College of Midwives guide to 
pregnancy and childbirth (RCM and Boots, 1997) features smiling women with pretty 
babies featured among many other commodities in the glossy advertisements. The 
style is light and the explanations brief. With Down’s syndrome (p 17) “People with 
Down’s syndrome usually need care and support for the whole of their lives.” So 
does everyone to some extent, and it is not clear how much more care people with 
Down’s syndrome receive or actually require.  
  A few articles take more positive approaches towards Down’s syndrome, such as 
one qualitative evaluation of support for ten mothers who chose to continue their 
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pregnancy after diagnosis of Down’s syndrome (Helm and Miranda, 1998). These 
articles are cautious. It is assumed that women need much extra support, and 
Atherton, (1996) warns, “Of course, the life of a child with a learning disability cannot 
be guaranteed to be trouble free”, although no one’s life can be so guaranteed. 
  A main change for midwives is their increasingly technical and scientific prenatal 
role, in explaining the range of tests and their statistically complex results, rather 
than concentrating, as in former decades, on physical and emotional care. A woman 
may be told for example, “You have a raised serum level of over 1 in 250”, possibly 
with mention of alphafetoprotein and human chorionic gonadotrophin. “There’s a 
higher chance you might have a handicapped baby. Do you want to have an amnio, 
to make sure?” The “handicap” may not be precisely explained, but if they are 
warned that “trisomy 13 is also a possibility, when the baby may die after a few 
weeks”, women may opt for a test hoping to resolve fears of more severe conditions 
than Down’s syndrome. There may be quite detailed explanations of Mendelian 
inheritance patterns, although these are irrelevant to the chromosomal and neutral 
tube disorders which maternal serum screening searches for. Some nurses welcome 
this new stage of nursing as raising the profession’s scientific status and authority 
(Sigmon et al., 1997). Yet evaluations suggest that practitioners tend not to 
understand or explain screening test results clearly (Smith, Shaw and Marteau, 
1994), thus raising ethical questions about the benefits of midwives’ increasing 
involvement in screening, which the literature does not clearly address.   
 
Mainstream bioethics and Down’s syndrome  
This section considers dominant and here called “mainstream” influences of 
bioethics on prenatal screening which both share a concern for non-directive 
methods of decision making, and also share influential underlying values. In the 
Journal of Medical Ethics (April 1999, 35,2) several articles interpret principles of 
social justice and personal autonomy to advocate increased medical authority over 
activities such as prenatal screening, informing families about their gene pool, 
preimplantation diagnosis, embryo selection and cloning. Other papers in this issue 
challenge what are identified as a eugenic and anti-disability stance in the former 
articles. The special issue illustrates the diversity and lively debates in bioethics, and 
also the way some influential bioethics authors overtly or implicitly apply bioethics 
principles in ways described later in this section. 
  It is crucial to emphasise that bioethics is often subtly and densely argued. 
However, mainstream bioethics principles (for example, Beauchamp and Childress, 
1983; Gillon, 1994; and as applied in Glover and Glover, 1996) are open to varying 
interpretations. Like any complex, influential philosophy, bioethics is inevitably liable 
to be widely understood and applied to specific practices in rather simplified ways. 
The main impact of sophisticated bioethics on health services policy and practice is 
mediated through they way busy practitioners apply the theories. So, in many clinical 
meetings I have observed, reference to ethics tends to be a check list of the main 
principles. This section shows how simplified prinicples can be interpreted in ways 
that raise problems for people with Down’s syndrome. The following section will 
review more complex bioethics analyses.   
  Respect for autonomy emphasises vital regard for the rational person’s body and 
mind, property and privacy, for protection from unwanted medical interventions, and 
for treating persons as ends in themselves and respecting their informed, voluntary 
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consent (Kant, 1948). Yet such respect can set an all-or-nothing standard, which 
offers no respect or protection to anyone deemed non-rational, such as people with 
Down’s syndrome, or not fully a person such as a fetus. The higher the respect for 
rational persons, the greater their potential power to treat nonpersons as property 
(Mendus, 1987; Brazier, 1996), especially if conflicting interests are framed, for 
example, as maternal rights versus child or fetal rights (Bromham et al., 1990). 
When the intellect is highly prized in definitions of human identity, and in bioethics 
decision making, this can further disadvantage people with the lesser or different 
kinds of understanding considered later.   
  Cost-effective justice in bioethics is the proper distribution of resources by merit or 
need. The frequent emphasis on cost-effectiveness leans towards limiting and 
rationing public resources in order to respect the rights of tax payers, to promote 
self-help and discourage dependence. These policies can pose problems for people 
with Down’s syndrome who need extra support. The implicit individualism in 
mainstream bioethics concepts of justice, similar to the individualised biological 
medical model of disability mentioned earlier, can ignore structural changes in 
society towards greater inclusion, which benefit people with Down’s syndrome.  
  Nonmaleficence rightly avoids unwanted and ineffective medical interventions. Yet 
harm is also defined as untreated or untreatable “disease” when Down’s syndrome 
is confused with physical or mental illness; as “wrongful life” when health 
professionals do not prevent the birth of a child with Down’s syndrome which is 
assumed to be a life not worth living; as the “suffering” which life with Down’s 
syndrome is believed to involve for the individual or the family. Harris (1990:172), 
referring to Down’s syndrome, speaks expansively of “suffering as shorthand for a 
whole range of disadvantageous conditions. I do not literally mean being in pain or 
being in discomfort”. Lilford (1990) describes women who “clearly regard a baby with 
Down’s syndrome as an infinitely worse outcome than losing a normal baby from a 
prenatal diagnostic procedure”. Tooley (1983), Kuhse and Singer (1985), and Harris 
(1985) advocate infanticide as well as feticide of impaired infants; they argue that, as 
non-persons unable to be conscious of consciousness or to value their life, these 
infants cannot be harmed. Nonmaleficence can cover the harm of withholding 
medical information, which thereby disrespects patients’ autonomy, decision making 
and potential to avoid the harm of having a child with Down’s syndrome.   
  Beneficence can mean to identify, treat, cure, palliate or prevent disease and to 
promote physical and mental health. Down’s syndrome, when seen as a set of 
untreatable and severe anomalies (Goodman and Scott, 1997) which could be taken 
as hopelessly unsusceptible to any medical beneficence except prevention through 
termination. When beneficence as caring or deciding for others appears to conflict 
with respect for autonomy, beneficence is criticised as the harm of paternalism. 
Health staff therefore aim to give non-directive information to enable competent 
people to make their own decisions.    
  All these principles help to promote patients’ interests and high standards of care 
although, as shown, they can be interpreted positively or negatively.   
 
 
Critical ethics 
The term “critical ethics” here covers bioethics and other literature which takes less 
clear cut, less popularised approaches, with greater account of the surrounding 
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social and political context, and of inner feelings and relationships than mainstream 
ethics tends to take. Critical texts raise important questions and reservations; they 
show how mainstream ethics, rather than being neutral, tends to be based 
subliminally against pregnancy, childbirth and disabled people. A few of the critical 
approaches are summarised here, on risk management, autonomy, xetc 
 Protecting women from risk paradoxically expose them to medical power Many 
feminists, like mainstream ethicists, promote women’s autonomy and independence, 
but they show how women are disadvantaged by inequalities of gender, income, 
education and control over power and resources (Ramazanoglu, 1989; Sherwin, 
1992), and how childbearing and child care hold women in subordinate positions 
and make them sick (Doyal, 1995). This can repeat the mother-child conflicts in 
mainstream ethics discussed above, and can paradoxically make women more 
vulnerable. The more the fetus’s future is seen as provisional and potentially hostile 
to the woman’s interests, as the threat or enemy within, open to clinical inspection 
ostensibly to offer women choice, the more licensed invasive prenatal care 
becomes. Efforts to protect women from risk, partly paradoxically, make them more 
vulnerable to intrusive services. Feminists criticise debates about in vitro (in glass) 
fertilisation which ignore women, but prenatal ultrasound literally renders the woman, 
and potentially her own autonomy, invisible.  
  Autonomy through relationships instead of isolation  Opportunity for choice helps 
women who unequivocally want an abortion. It does not necessarily help women 
during a longed-for pregnancy, those who are uncertain about accepting a disabled 
child, cases when the severity of the fetal condition is unknown, women who would 
rather accept fate than take on responsibility through choice, those who identify 
parenthood with unconditional acceptance of the child, or who want to enjoy a 
fulfilling rather than a tentative (Rothman, 1994) pregnancy. Setting the assumed 
interests of these women potentially against the fetus can deny them autonomy, 
while aiming to safeguard it.  
  Ross (1995) and Adams (1995) review contradictions about motherhood when 
medicine and psychology tend to denigrate yet also to fear it, and when women and 
children struggle with the contradictions of motherhood as very fulfilling yet 
constraining. They review how problematic masculine concepts of autonomy and 
justice are for women. The morality of motherhood tends to be analysed crudely, as 
fitting neither public, masculinist principles of disinterested duty to the abstract 
unknown other, not intimate relationships, which Kant (1948) did not count as moral 
because they are “instinctive” and mutually rewarding not sacrificially altruistic 
(Seidler, 1986; Benhabib and Cornell, 1987). Yet this ignores how very demanding 
parenting can be.  
  Kantian extremes of isolated autonomy, never being another person’s means, are 
incompatible with pregnancy and motherhood: women are the means for their future 
children’s existence, and children inevitably invade their parents’ liberty and use their 
property.  Human autonomy, when defined in intellectual terms (to be conscious of 
consciousness) excludes children and people with learning difficulties (if they are 
assumed to be unselfconscious). When Kantian autonomy is assumed to be neutral, 
factual and universal, rather than a quite recent Western theory about male 
humanity, it can covertly bias prenatal consultations and policies, and endorse 
hostility towards the fetus, more so to an impaired fetus, as a threat to the woman’s 
autonomy. A child with Down’s syndrome is seen as making far above average 
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demands on the parents, being exceptionally dependent, and giving far less 
satisfaction. Prenatal decision-making and the related literature, including this paper, 
are intellectualised , drawing on philosophy, science and statistics. Yet human 
relationships are perhaps far more to do with doing and feeling ways forward 
through experience. A sociology of prenatal decision making and ethics could 
helpfully ground these events in the everyday experiences from which they are partly 
artificially lifted by new technologies.     
  Mainstream bioethics often slips over the crucial public/private distinction by 
treating “respect for autonomy” as if it applies equally to all relationships, including 
mother and child ones, or else as if, without full equal autonomy, a relationship is not 
a fully human, ethical  one. When ethicists deny that the fetus “exists” as a person or 
potential person, this can dismiss abortion as a non-event, as if there is no form of 
life to end.  
  The mother-child psycho-biological relationship is stretched into a model for all 
social-economic relationships, and burdened into being a source and symbol of 
healthy or unhealthy societies (such as when crime is blamed on poor mothering). 
So traditionally, men were seen as guaranteeing order as “gatekeeper(s) between 
public and private spheres, while women and especially mothers represent the 
disorderly matter that must be sorted out” (Adams, 1995:416). These subliminal 
psychological and political fears help to explain why modern policy makers promote 
technologies to regulate reproduction, despite scarce prenatal resources and 
staffing. Pfeffer (1993) shows why there is little public debate about these funding 
decisions, because governments are loathe to be openly associated with potentially 
eugenic services. They eschew ”front door” public programmes, and use ”backdoor” 
approaches of offering women individual choices (Paul, 1992), although the net 
effect is the same in the reduction of birth rates of certain conditions. The 
acceptance of very high costs per Down’s syndrome birth prevented, mentioned 
earlier, may be explained partly by general masculine fears of unregulated fertility.    
  
  Referring to research such as Oakley’s (1993), Adams (1995:427) comments that 
some feminists see that mothers function “often against great adversity” to balance 
“both emotional/biological and social/economic levels [thereby] mothers have 
brought about profound social and economic changes that outstrip the interpretative 
power of representations of motherhood”. Detailed studies of women’s ambivalence, 
for example after learning their fetus has Downs’s syndrome (Santalahti et al., 1998) 
or their conflicting feelings about their disabled child (Larson, 1998) show the 
contrast between the relative clarity of mainstream ethics and the complex realities. 
“In the embrace of paradox mothers created a positive bias and regained a sense of 
control that fuelled their optimism in maternal work” (Larson, 1998).  
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  Noting similar ambiguities in lay people’s views on the new genetics Cunningham-
Burley et al. (1998) believe that “rather than being a reason to discount lay views, we 
suggest that ambivalence should be a resource for critical discussion of the new 
genetics”. Jallinoja (1998) and Jallinoja et al. (1998) agree that “contradictory 
attitudes towards genetic testing should be given greater significance” in research 
and in clinical practice. Gilligan’s (1982) research, showing how men tend to fear 
intimacy and women to be reassured by it, helps to explain gender differences 
between isolationist mainstream ethics and “critical ethics”, mainly by women, that 
takes greater account of relationships and feelings. Feminists tend to see autonomy 
as realised and enriched through relationships, in which people are fulfilled rather 
than diminished. These and other research propose different concepts through 
which to research pregnant women’s responses to screening and disability. 
  Paradoxes of fear and reassurance  Screening is presented as benignly intended 
“to reassure that the baby is all right”. Yet in contrast with requested opt-in testing for 
a specific familial condition, the screening of large asymptomatic groups is 
complicated. Screening can never tell if the baby is “all right” - free from any 
potential anomaly. Fears raised in previously unaware women have to be soothed 
by screening staff, and the stronger the reassurance, the more this implies that 
women are rightly very afraid of having a disabled child, without outswimming how 
informed or realistic their responses are. Midwives may feel that sadness at 
terminating a pregnancy is not as bad as the grief, shock, anger and denial parents 
are supposed to feel after the birth a disabled child. Yet the few studies of women’s 
reactions after termination for fetal abnormality suggest that it does not prevent 
distress (Marteau, 1995), and a study of parents of children with Down’s syndrome 
reported that the parents felt that the maternity staff expressed shock and grief 
which they, the parent did not particularly share (Goodey, 1991).  
  The fabric of morality  Grimshaw (1986) discusses how mainstream philosophers 
dismiss living experiences as “household rubbish” to be cleared away in order to 
examine the universal abstract principles they illustrate. But she argues that moral 
dilemmas are actually constituted from their social and political context and from 
personal experiences. Gilligan (1982), advocating a more socially contextual and 
compassionate  “ethic of care” to complement the mainstream ethic of justice, 
illustrates how women take account of practical small and large influences when 
trying to resolve conflicting obligations to their self and to others, in dilemmas about 
abortion. (Alderson, 1990). Care can complement and express respect rather than 
inevitably compromising or conflicting with autonomy. Everyone is realistically 
recognised as being interdependent, neither simply non-autonomously dependent 
nor autonomously isolated. 
  Debates about maternal versus fetal rights look less conflictual when set in their 
political context. Women are most pressed to consider abortion when they lack 
support and resources, so in many ways the mother and potential child share 
disadvantages which often require political solutions (Callahan and Knight, 1992) - 
reasonable support, income and appropriate employment for parents who wish to 
spend time with their children.  
  Redistributive justice    Rationing and cost cutting in public spending have dire 
effects on children across the world (O’Neill, 1996), and it is a heavy responsibility to 
have any child, still more a disabled one. However, disabled researchers have 
moved on from concepts of justice as equal treatment for all, to the importance of 
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equal opportunity to assist equal outcomes and, from there, also to respect for 
difference, rather than futile, oppressive attempts to standardise people (Philpot and 
Ward, 1995; Oliver, 1996). Respect for diversity involves working to change the 
status quo which mainstream ethics tends to support, by redistributing resources 
more fairly, and changing unjust laws and segregational systems in education and 
employment, transport and housing, systems which follow medically guided patterns 
of discrimination (Oliver, 1996).  
 
  Mainstream bioethics tends to reinforce rather than question masculine values that 
dominate the prenatal services, which primarily control women (Stacey, 1992). 
These values include covert patriarchal assumptions about property rights and 
inheritance through worthy heirs. Notions of intellectual disability originated in legal 
disputes about proof that an heir was competent and not a “fool” whose estate could 
pass to the monarchy, and in the physician John Locke’s linking of concepts of 
mental competence to rights, democracy, autonomy and consent (Goodey, 1996). 
Rather than assuming a solid philosophical base here, it could be useful to unravel 
the assumptions and their implicit influences.  
  Risk management calculations can look just and rational when reduced to 
mathematical terms. For example, tests are justified when the “risk from the 
investigations is no greater than the risk of having an affected fetus”. Then, a one 
per cent risk of abortion after amnio is justified ethically if there is at least a one per 
cent chance that the fetus will have Down’s syndrome. Yet the reasoning is not 
logical, when it measures only the probability of a result and not its severity. Parents 
might be offered amnio with a one per cent risk of miscarriage against a 50 per cent 
risk that the child will have unwanted brown eyes instead of blue. On risk incidence, 
the amnio would be entirely justified, but on risk severity, few people would accept 
the choice as ethical. How closely does Down’s syndrome become an aesthetic 
choice like eye colouring? Harris (1990) argues for parents’ rights to choose 
characteristics like eye colour or (in an interestingly racist example) a lighter skin 
colour, as part of the accepted morality of furthering the child’s interests and 
potential. He ignores the frustrations that ensue when parents treat children as their 
property, make unrealistic demands, and give only highly qualified competitive 
approval instead of unconditional love.  Brazier (1996) illustrates how technologies 
which treat sperm and ova as commodities affect attitudes towards children and 
their legal rights. Harris’s view gives ethical respectability to values which feminists 
criticise, of treating potential children as “consumer objects subject to quality control 
[and assumes that] certain fetal conditions are intrinsically not bearable” (Lippman, 
1991). 
   
Conclusion  
Oakley (1984:292-3), quoting Fritjof Capra, warned of destructive splits in prenatal 
policies between reason over intuition, science over religion, competition over 
cooperation, and  exploitation of natural resources over conservation, of broadly 
masculine over feminine  values. The increase since then in terminations of “wanted 
but impaired” pregnancies further illustrates (OPCS 1994)  the contrast which 
Ruddick (1990) points out between the desire to control, intervene, correct or 
destroy, versus “maternal” responses of holding, observing, negotiating and 
adapting. In the controlling model, risk and failure are feared when personal 
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responsibility is paramount. In the holding model, with less aim to be in control, risks 
may be opportunities that bring unexpected supports as well as difficulties.  
  Paradoxically, public screening programmes invade what were the most private 
areas of family life, yet are also among the trends moving child care away from 
being a shared public responsibility towards a private responsibility for parenthood 
(O’Neill, 1994), partly by presenting prenatal decisions as personal choices, and 
concealing the political pressures. The valuable principle of autonomous choice can 
be oppressive when it obscures social injustices when women individually have to 
bear so much responsibility for caring for the next generation. This can make a 
decisions to “do nothing” (have the baby) seem a selfish extravagance, wasting 
resources on a life that it is kinder to prevent. 
  In summary, the concerns in mainstream bioethics about potentially harmful loss of 
control and the threat of intimacy also powerfully influence values, policies, practices 
and research in prenatal screening. A vital part of social research about screening, 
as in this review, is to clarify these often covert values in the light of alternative ones. 
Stacey (1996:332) discusses the power which technologies like screening put into 
the hands of the few, and the way this goes unrecognised  and unaddressed. She 
argues not for obstructing new technologies but for bringing new understanding to 
them, more widely and systematically, about their social context, in order to reduce 
avoidable suffering. 
  While a direct influence of bioethics on medical policies cannot be proved, it is 
indicated by, for example, the popularity among health practitioners and policy 
makers of bioethics courses and conferences, and the numbers of doctors and 
nurses writing about ethics and references to bioethics in policy reports. Certainly, 
the alternative range of feminist, disability and social science literature, here termed 
“critical ethics”, appears to have little impact on prenatal health policies and 
counselling, even if it influences nursing ethics.    
  Choice either way loads women with responsibility and potential for guilt and 
blame. To refuse the tests may appear to be casual, even callous, to accept the birth 
of an impaired child, expected or not, can look like selfish extravagance and can 
become a lonely burden. Critical analysis of prenatal choices is restricted by sharp 
divisions of viewpoints into either pro-life or pro-choice faction and attempts to look 
at the complex middle ground of abortion for a longer-for but impaired baby tend to 
be dismissed by each side as siding with the opposing faction.   
  Feminists, including disabled ones, particularly defend women’s right to abortion, 
as a vital  practical and symbolic key to respect for women’s physical and mental 
autonomy. As a disabled woman, Degener (1990) tries to reconcile feminist and 
disability rights by saying that at least women contemplating abortion of an impaired 
but wanted fetus should “know” what they are doing, but that is as far as she goes. 
Arguably, to know but not to change what you do is no gain, although the more 
people know about prenatal screening, the less likely they are to use it (Marteau and 
Coyle, 1998).  
  This paper has taken Degner’s point further, of “knowing” what prenatal decisions 
involve. It has shown how, far from being neutral, screening and bioethics can be 
used to support policies which are negative towards motherhood in general, and 
also to disability and learning difficulties. A companion paper examines knowing in 
terms of evidence about living with Down’s syndrome based on interviews with 
adults with Down’s syndrome (Alderson, forthcoming).Can a life with Down’s 
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syndrome worth living? In an era of evidence based medicine, evidence about the 
value and quality of life with Down’s syndrome is urgently needed. Equally vital is 
greater understanding of the underlying bioethics assumptions which influence our 
attitudes towards prenatal choice and learning difficulty and which this paper has 
attempted to clarify.  
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